Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

From the category archives: OBN News

Company announcement

Fuel3D to establish new headquarters on The Oxford Science Park

Company to be first occupier of the Park’s state-of-the-art Schrödinger Building

Read the rest of entry »

Celebrating two years in business!

Arcinova was launched in February 2016, following the acquisition of the Covance site in Alnwick, by Arc Trinova Limited, a new company formed by Ian Shott and Paul Ryan, owners of Shott Trinova LLP.

Read the rest of entry »

Award of New Innovate UK Grant

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens, is pleased to announce that is has been awarded a new grant by Innovate UK, the UK’s innovation agency.  The grant, awarded as part of Innovate UK’s Precision Medicine competition, will support the project “Prostate Cancer Chemotherapy Precision Dosing”.

Read the rest of entry »

Congenica Achieves Global ISO 13485:2016 in vitro Diagnostic Device Quality Management Systems Certification

Congenica, a global provider of clinical genomics interpretation software, announced today that it has received certification in ISO 13485:2016, a quality management system for medical devices that supports comprehensive policies and processes across the entire business.

Read the rest of entry »

Mologic Visited by Minister of State Alistair Burt

On the 19th of February, Mologic were visited by Minister of State and NE Beds MP @AlistairBurtUK to hear all about their malaria diagnostics research. He was especially interested from the perspective of the Department for International Development.

Read the rest of entry »

Prokarium secures $10 million investment from Saudi, Swedish and Korean investors for clinical development of revolutionary thermostable vaccines

Prokarium, the UK-based synthetic biology company that has developed Vaxonella, an oral, thermostable vaccine delivery platform, today announced the completion of a $10 million investment round.

Read the rest of entry »

Mologic partners with Fraunhofer on point-of-care diagnosis and antibiotic susceptibility test for UTIs.

Mologic is proud to announce a partnership with Fraunhofer on point-of-care diagnosis and antibiotic susceptibility test for Urinary Tract Infections.

Read the rest of entry »

Congenica and SFI Research Centre FutureNeuro Unite to Deliver More Accurate Diagnoses for Genetic Epilepsy

 New software to deliver faster and more accurate diagnoses in genetic epilepsies is the ambition of a ground-breaking partnership between Congenica, a global provider of clinical genomics interpretation software, and FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, supported by Science Foundation Ireland. The software will be designed to work with electronic health record (EHR) systems, including the Irish electronic health record for Epilepsy, so that the entire diagnostic process, from initial DNA sequencing to determining treatment options, is available to clinicians and patients through their electronic records.

Read the rest of entry »

Cello Health announces launch of new business Cello Health Logic

Cello Health has today announced the launch of their new social media insight and analytics business, Cello Health Logic. The business, born out of Cello Health Insight’s dedicated digital division, aims to meet the need for pharmaceutical and healthcare clients to tap into and better understand the huge volume of real-world conversational data that has the potential to drive strategic decision making.

Read the rest of entry »

Absolute Antibody and Kerafast Merge to Increase Access to Unique Reagents and Recombinant Antibody Technology

Absolute Antibody Ltd., an Oxford, UK-based company with a vision to make recombinant antibody technology accessible to all, and Kerafast Inc., a Boston, MA-based company with a mission to facilitate access to unique laboratory-made reagents, today announced a merger of the two companies.

Read the rest of entry »

Pages: Previous1234567...14NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us,, and we will post.